- Home
- NFGC vs PRME Comparison
NFGC vs PRME Comparison
Compare NFGC & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NFGC | PRME |
|---|---|---|
| Founded | 2016 | 2019 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 588.1M | 601.1M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | NFGC | PRME |
|---|---|---|
| Price | $3.03 | $3.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $5.00 | ★ $9.31 |
| AVG Volume (30 Days) | 1.5M | ★ 4.0M |
| Earning Date | 11-07-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,977,000.00 |
| Revenue This Year | N/A | $179.58 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 647.13 |
| 52 Week Low | $0.93 | $1.11 |
| 52 Week High | $3.03 | $6.94 |
Technical Indicators
Market Signals| Indicator | NFGC | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 77.03 | 49.25 |
| Support Level | $2.03 | $3.26 |
| Resistance Level | $2.90 | $3.89 |
| Average True Range (ATR) | 0.16 | 0.33 |
| MACD | 0.10 | 0.06 |
| Stochastic Oscillator | 99.40 | 84.62 |
Price Performance
Historical ComparisonAbout NFGC New Found Gold Corp
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.